No Bull: We Got a Shift in Sentiment

We didn't get too bullish with Tuesday's action, but we got a change in sentiment. Let's look at new lows, breadth, and more.

Top Stock Picks for 2022 in Biotech and Genetics

Seven investment experts participating in Moneyshow's Top Picks 2022 report share their ideas for healthy portfolio gains in 2022.

Traders Get a Day of Relief

It was a nice relief bounce after the selling pressure over the past week, but Wednesday morning's consumer price index report could easily shake things up.

5 Thoughts on the Tech Sector Following a Volatile Start to 2022

Bargains can be found, but there are reasons to think the growth-stock selloff that began in November hasn't ended yet.

Let's Take the Wheel of Cerence

I've got CRNC on my screen as the automotive tech company gave up much of its value exiting 2021.

Will Shake Shack Investors Get Burnt?

As SHAK gaps higher, let's see if the gains can be sustained.

Bulls Will Have to Go Further Down Creek With Danaher

The longer-term trend of DHR is bullish, but we first must deal with the sideways action.

The Death of Mutual Funds Has Been Somewhat Exaggerated

As mutual fund issuers continue to explore the ETF marketplace, investors will likely get more options. Here's what to watch.

What Bubble-Era Cisco Can Tell Us About Zoom and Other Pandemic Stocks

If Cisco was in a bubble back then, arguably Zoom's recent bubble was an even bigger one.

Cenovus Energy Is Breaking Out of a Long Base Formation

We have two new price targets.